0001437749-26-004343
SEC filingcbdMD, Inc. (YCBD) reported Q1 2025 results with total net sales of $5.0M, matching gross sales, and gross profit of $3.0M after $2.0M in cost of sales, yielding a 60% gross margin. Operating expenses of $3.3M drove a $286K operating loss, with $3K interest income resulting in a pre-tax loss of $283K and net loss of $283K. After $41K preferred dividends, net loss attributable to common shareholders was $325K. Basic and diluted loss per share was -$0 on 9.0M weighted average shares. Balance sheet shows total assets of $11.8M, including $8.2M current assets with $3.4M cash, against $2.8M current liabilities, yielding $9.0M shareholders' equity. Cash flow from operations used $812K, investing used $165K for property and equipment, offset by $2.1M from preferred stock issuance, netting $1.1M cash increase to $2.3M end-period cash. No prior period comparisons disclosed in filing.
cbdMD, Inc. reported Q1 2025 net sales of $5.0M, with gross profit of $3.0M after $2.0M cost of sales. Operating expenses totaled $3.3M, resulting in a $286K loss from operations. Interest income of $3K led to a pre-tax loss of $283K and net loss of $283K. Preferred dividends of $41K reduced net loss attributable to common shareholders to $325K. Basic and diluted loss per share was -$0 on 9.0M weighted average shares. Total assets stood at $11.8M, with $9.0M shareholders' equity. No prior quarter or year comparisons provided in the filing. Cash position strengthened via financing activities.
Total net sales were $5.0M, equal to gross sales, indicating no significant deductions. No segment breakdowns, geographic mix, or growth drivers disclosed in the filing. Revenue performance reflects core operations without detailed attribution.
gross margin was 60.0% ($3.0M gross profit on $5.0M sales). Operating margin was -5.7% due to $3.3M operating expenses exceeding gross profit by $286K. No cost structure changes or margin trends versus prior periods disclosed.
Operating activities used $812K cash, adjusted from -$283K net loss by $191K intangibles amortization, $248K inventory improvement, offset by $277K payables decline. Investing used $165K for property and equipment. Financing provided $2.1M from preferred stock, netting $1.1M cash increase. Ending cash $2.3M (starting implied $1.2M, though beginning not stated). Balance sheet: $11.8M assets ($8.2M current, $3.4M cash), $2.8M liabilities (all current), $9.0M equity. No debt beyond leases.
No management guidance, strategic priorities, or risk factors explicitly disclosed in the provided filing content.